NCT01824836 2025-05-31
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
Clinical Trials
10 trialsNCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
NCT01004744 2021-01-11
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
Columbia University
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT01153672 2019-09-06
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Phase NA Completed
NCT01155089 2018-01-23
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
West-Ward Pharmaceutical
Phase NA Completed
NCT01155102 2018-01-23
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions
West-Ward Pharmaceutical
Phase NA Completed
NCT00612560 2017-10-12
FABrC
Roswell Park Cancer Institute
Phase NA Completed
NCT01016665 2009-11-19
Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
Federal University of São Paulo
Phase NA Completed
NCT00437853 2007-02-21
Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer
Instituto Nacional de Cancerologia de Mexico
Phase NA Completed